ARS Pharmaceuticals Cash Flow Statement (2020-2026) | SPRY

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-0.04B0.05B-0.01B-0.01B-0.02B-0.02B-39.41B-38.20B-15.46B-0.01B-0.09B-0.07B-0.16B0.05B-0.04B-0.22B-0.11B-0.04B-0.10B-0.10B
Depreciation and Depletion (Quarter)
0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Share-based Compensation (Quarter)
0.01B-0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.01B-0.00B0.07B0.05B
Gains from Investment Securities (Quarter)
-0.00B-0.00B0.00B
Cash from Operations (Quarter)
-0.02B0.03B-0.01B-0.01B-0.01B-0.02B-0.01B-0.02B-0.01B-0.02B-0.01B-0.01B-0.01B0.04B-0.04B-0.04B-0.05B-0.04B-0.04B-0.06B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Amortization of Deferred Charges (Quarter)
-0.00B0.00B0.00B-0.00B0.00B
Depreciation & Amortization (CF) (Quarter)
0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Change in Working Capital
Change in Receivables (Quarter)
0.00B0.01B0.00B0.01B0.01B-0.01B0.00B0.02B
Change in Inventory (Quarter)
0.00B0.01B0.01B0.00B-0.00B0.01B0.00B-0.00B
Change in Accured Expenses (Quarter)
-0.00B-0.01B0.00B-0.00B0.00B-0.01B0.00B0.00B0.00B-0.01B0.00B0.00B0.00B0.01B0.00B0.01B0.01B-0.01B0.01B0.01B
Other Working Capital Changes (Quarter)
0.00B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B0.00B0.00B-0.00B-0.00B0.00B0.01B0.00B-0.00B-0.00B-0.00B0.00B0.00B
Investing Activities
Capital Expenditures (Quarter)
0.00B-0.00B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.01B-0.01B
Change in Acquisitions & Divestments (Quarter)
0.02B0.04B0.06B0.06B0.06B0.07B0.06B0.07B0.06B0.08B0.09B0.07B0.04B0.06B
Cash from Investing Activities (Quarter)
-0.04B0.04B-0.00B-0.00B-0.00B-0.00B-0.11B0.04B-0.05B0.03B-0.01B-0.01B0.02B-0.10B0.03B0.05B-0.04B0.02B0.03B0.04B
Financing Activities
Other financing activities (Quarter)
0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Cash from Financing Activities (Quarter)
0.00B0.05B-0.00B-0.00B-0.00B0.19B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.07B0.00B0.00B0.10B0.00B0.00B0.00B
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
0.05B
Additional items
Change in Cash (Quarter)
-0.06B0.12B-0.01B-0.01B-0.01B0.17B-0.12B0.03B-0.06B0.01B-0.01B-0.02B0.00B0.01B-0.01B0.01B0.01B-0.02B-0.02B-0.02B
Free Cash Flow (Quarter)
-0.02B0.03B-0.01B-0.01B-0.01B-0.02B-0.01B-0.02B-0.01B-0.02B-0.01B-0.01B-0.01B0.04B-0.04B-0.05B-0.04B-0.04B-0.04B-0.06B
Net Cash Flow (Quarter)
-0.06B0.12B-0.01B-0.01B-0.01B0.17B-0.12B0.03B-0.06B0.01B-0.01B-0.02B0.00B0.01B-0.01B0.01B0.01B-0.02B-0.02B-0.02B